Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBIV
3276
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $268K | ﹤0.01% |
22,881
-7,652
| -25% | -$135K |
|
3277
Adicet Bio
ACET
$85.6M
| $266K | ﹤0.01% |
+1,856
| New | +$463K |
|
3278
Milestone Pharmaceuticals
MIST
$143M
| $266K | ﹤0.01% |
+67,200
| New | +$354K |
|
|
OPI
3279
DELISTED
Office Properties Income Trust
OPI
| $266K | ﹤0.01% |
+19,955
| New | +$287K |
|
3280
Arq
ARQ
$88M
| $266K | ﹤0.01% |
109,545
+55,500
| +103% | +$151K |
|
3281
COPT Defense Properties
CDP
$4.24B
| $265K | ﹤0.01% |
+10,200
| New | +$262K |
|
3282
Nektar Therapeutics
NKTR
$2.47B
| $265K | ﹤0.01% |
+7,807
| New | +$378K |
|
|
RPT
3283
Rithm Property Trust
RPT
$95.4M
| $265K | ﹤0.01% |
6,083
+100
| +2% | +$4.67K |
|
3284
Planet Labs
PL
$7.97B
| $264K | ﹤0.01% |
60,800
-231,300
| -79% | -$1.2M |
|
3285
Healthpeak Properties
DOC
$15B
| $263K | ﹤0.01% |
+10,500
| New | +$255K |
|
3286
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
| $263K | ﹤0.01% |
6,794
-1,706
| -20% | -$62.3K |
|
3287
The Greenbrier Companies
GBX
$1.54B
| $262K | ﹤0.01% |
+7,800
| New | +$260K |
|
3288
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3B
| $262K | ﹤0.01% |
+5,200
| New | +$256K |
|
|
RDGT
3289
Ridgetech Inc
RDGT
$2.58M
| $262K | ﹤0.01% |
24
-2
| -8% | -$14.1K |
|
|
CVT
3290
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $262K | ﹤0.01% |
48,600
+8,800
| +22% | +$48.8K |
|
3291
Compass Therapeutics
CMPX
$340M
| $261K | ﹤0.01% |
51,900
-12,315
| -19% | -$49.1K |
|
3292
Magnachip Semiconductor
MX
$134M
| $261K | ﹤0.01% |
+27,843
| New | +$269K |
|
|
YMAB
3293
DELISTED
Y-mAbs Therapeutics
YMAB
| $261K | ﹤0.01% |
53,500
-74,400
| -58% | -$541K |
|
|
LONA
3294
LeonaBio Inc
LONA
$72.1M
| $260K | ﹤0.01% |
8,210
-15,290
| -65% | -$482K |
|
|
CTO
3295
CTO Realty Growth
CTO
$817M
| $260K | ﹤0.01% |
14,201
-79,500
| -85% | -$1.53M |
|
3296
Talkspace
TALK
$874M
| $260K | ﹤0.01% |
426,010
-74,590
| -15% | -$57.4K |
|
3297
GeoVax Labs
GOVX
$3.87M
| $259K | ﹤0.01% |
1,095
-1,693
| -61% | -$514K |
|
|
NAAS
3298
NaaS Technology Inc
NAAS
$55.6M
| $259K | ﹤0.01% |
208
-48
| -19% | -$69.8K |
|
3299
Equinox Gold
EQX
$8.14B
| $258K | ﹤0.01% |
78,600
-91,200
| -54% | -$315K |
|
3300
Disc Medicine
IRON
$3.03B
| $258K | ﹤0.01% |
12,970
+6,975
| +116% | +$347K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.